WO2023004608 - L-ERGOTHIONEINE AND THERAPEUTIC USES THEREOF

National phase entry:
Publication Number WO/2023/004608
Publication Date 02.02.2023
International Application No. PCT/CN2021/108809
International Filing Date 28.07.2021
Title **
[English] L-ERGOTHIONEINE AND THERAPEUTIC USES THEREOF
[French] L-ERGOTHIONÉINE ET SES UTILISATIONS THÉRAPEUTIQUES
Applicants **
NANJING NUTRABUILDING BIO-TECH CO., LTD.
Inventors
WANG, Mingru
YI, Ronghua
WELLS, Shawn
LIAO, Kylin
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1880
EPO Filing, Examination, Granting15629
Japan Filing, Examination, Granting2400
South Korea Filing, Examination, Granting2569
USA Filing, Examination, Granting6540
MasterCard Visa
Total: 29,018

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] L-ergothioneine, novel forms of L-ergothioneine, and therapeutic uses thereof, particularly for immune support and nutrient supplementation.[French] L'invention a trait à la L-ergothionéine, de nouvelles formes de L-ergothionéine, et leurs utilisations thérapeutiques, en particulier pour le support immunitaire et la supplémentation nutritionnelle.